1997, Medical ethics series., ISBN 9780253332189, xiv, 385
Book
European Journal of Heart Failure, ISSN 1388-9842, 2008, Volume 10, Issue 10, pp. 933 - 989
OBSTRUCTIVE PULMONARY-DISEASE | CONVERTING-ENZYME INHIBITORS | CARDIAC & CARDIOVASCULAR SYSTEMS | RECENT MYOCARDIAL-INFARCTION | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | LEFT-VENTRICULAR DYSFUNCTION | CARDIOVASCULAR-MAGNETIC-RESONANCE | CARDIAC-RESYNCHRONIZATION THERAPY | PLACEBO-CONTROLLED TRIAL | CLINICAL-TRIALS UPDATE | CORONARY-ARTERY-DISEASE | Cardiovascular Agents - therapeutic use | Heart Failure - therapy | Acute Disease | Humans | Diagnostic Techniques, Cardiovascular | Heart Failure - diagnosis | Chronic Disease | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article
1995, 1st ed., ISBN 0826512607, xvi, 323
Book
2001, 2nd ed., ISBN 9780727916150, xvii, 94
Terminally ill | Decision Making | Terminal care | Withholding Treatment | standards | Proxy | Great Britain | Right to life | Mental Competency | Life support systems (Critical care) | Adult | Euthanasia, Passive | Moral and ethical aspects | Life Support Care | Nutritional Support | Advance Directives | Minors | Persistant Vegetative State
Book
2013, ISBN 1107029198, xv, 440
Brain dysfunction is a major clinical problem in intensive care, with potentially debilitating long-term consequences for post-ICU patients of any age. The...
Brain | Treatment | Minimal brain dysfunction | Diagnosis | Wounds and injuries | Diseases
Brain | Treatment | Minimal brain dysfunction | Diagnosis | Wounds and injuries | Diseases
Book
JAMA, ISSN 0098-7484, 09/2015, Volume 314, Issue 10, pp. 1052 - 1062
IMPORTANCE: Chronic diseases have overtaken acute diseases, such as infections, as the major cause of premature mortality worldwide. Diabetes mellitus, a...
LIFE-STYLE INTERVENTION | BLADDER-CANCER | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | INTENSIVE TREATMENT | GLUCOSE CONTROL | INSULIN ANALOGS | CARDIOVASCULAR OUTCOMES | FOLLOW-UP | EUROPEAN ASSOCIATION | BETA-CELL FUNCTION | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Prediabetic State - blood | Blood Glucose - analysis | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Risk Factors | Prediabetic State - drug therapy | Diabetes Mellitus, Type 1 - drug therapy | Prediabetic State - diagnosis | Diabetes Mellitus, Type 1 - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - blood | Thiazolidinediones - therapeutic use | Hyperglycemia - diagnosis | Diabetes Mellitus, Type 1 - blood | Glucagon-Like Peptides - therapeutic use | Sodium-Glucose Transport Proteins - antagonists & inhibitors | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Care and treatment | Usage | Diabetes | Diagnosis | Risk factors | Prevalence studies (Epidemiology) | Disease prevention | Epidemics | Medical treatment | Cardiovascular disease | Disease management | Medical diagnosis
LIFE-STYLE INTERVENTION | BLADDER-CANCER | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | INTENSIVE TREATMENT | GLUCOSE CONTROL | INSULIN ANALOGS | CARDIOVASCULAR OUTCOMES | FOLLOW-UP | EUROPEAN ASSOCIATION | BETA-CELL FUNCTION | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Prediabetic State - blood | Blood Glucose - analysis | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Risk Factors | Prediabetic State - drug therapy | Diabetes Mellitus, Type 1 - drug therapy | Prediabetic State - diagnosis | Diabetes Mellitus, Type 1 - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - blood | Thiazolidinediones - therapeutic use | Hyperglycemia - diagnosis | Diabetes Mellitus, Type 1 - blood | Glucagon-Like Peptides - therapeutic use | Sodium-Glucose Transport Proteins - antagonists & inhibitors | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Care and treatment | Usage | Diabetes | Diagnosis | Risk factors | Prevalence studies (Epidemiology) | Disease prevention | Epidemics | Medical treatment | Cardiovascular disease | Disease management | Medical diagnosis
Journal Article
Chest, ISSN 0012-3692, 07/2017, Volume 152, Issue 1, pp. 143 - 149
Malignant pleural mesothelioma is a highly aggressive tumor associated with asbestos exposure. There are few effective treatment options for mesothelioma, and...
mesothelioma | screening | biomarkers | PROSTATE | PLEURAL MESOTHELIOMA | TUMOR-MARKERS | MEGAKARYOCYTE POTENTIATING FACTOR | CANCER | SOLUBLE MESOTHELIN | TRIAL | OSTEOPONTIN | RESPIRATORY SYSTEM | SERUM MESOTHELIN | ASBESTOS | CRITICAL CARE MEDICINE | Mesothelioma - therapy | Prognosis | Early Detection of Cancer - methods | Mesothelioma - pathology | Humans | Lung Neoplasms - pathology | Lung Neoplasms - therapy | Pleural Neoplasms - therapy | Biomarkers, Tumor - blood | Mesothelioma - blood | GPI-Linked Proteins - blood | Pleural Neoplasms - blood | Lung Neoplasms - blood | Pleural Neoplasms - pathology | Mesothelioma | Care and treatment | Research | Diagnosis | Biological markers | Cancer
mesothelioma | screening | biomarkers | PROSTATE | PLEURAL MESOTHELIOMA | TUMOR-MARKERS | MEGAKARYOCYTE POTENTIATING FACTOR | CANCER | SOLUBLE MESOTHELIN | TRIAL | OSTEOPONTIN | RESPIRATORY SYSTEM | SERUM MESOTHELIN | ASBESTOS | CRITICAL CARE MEDICINE | Mesothelioma - therapy | Prognosis | Early Detection of Cancer - methods | Mesothelioma - pathology | Humans | Lung Neoplasms - pathology | Lung Neoplasms - therapy | Pleural Neoplasms - therapy | Biomarkers, Tumor - blood | Mesothelioma - blood | GPI-Linked Proteins - blood | Pleural Neoplasms - blood | Lung Neoplasms - blood | Pleural Neoplasms - pathology | Mesothelioma | Care and treatment | Research | Diagnosis | Biological markers | Cancer
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 2/2018, Volume 23, Issue 1, pp. 1 - 34
Japanese mortality due to colorectal cancer is on the rise, surpassing 49,000 in 2015. Many new treatment methods have been developed during recent decades....
Chemotherapy | Medicine & Public Health | Surgery | Colorectal cancer | Oncology | Cancer Research | Guideline | Endoscopy | Radiotherapy | Surgical Oncology | INTENSIVE FOLLOW-UP | FLUOROURACIL PLUS LEUCOVORIN | INTERVAL HEPATIC RESECTION | WILD-TYPE KRAS | FRAIL ELDERLY-PATIENTS | TOTAL MESORECTAL EXCISION | SINGLE-AGENT PANITUMUMAB | PHASE-III TRIAL | LYMPH-NODE METASTASIS | ONCOLOGY | HIGH-DOSE LEUCOVORIN | Practice guidelines (Medicine) | Care and treatment | Cancer | Special
Chemotherapy | Medicine & Public Health | Surgery | Colorectal cancer | Oncology | Cancer Research | Guideline | Endoscopy | Radiotherapy | Surgical Oncology | INTENSIVE FOLLOW-UP | FLUOROURACIL PLUS LEUCOVORIN | INTERVAL HEPATIC RESECTION | WILD-TYPE KRAS | FRAIL ELDERLY-PATIENTS | TOTAL MESORECTAL EXCISION | SINGLE-AGENT PANITUMUMAB | PHASE-III TRIAL | LYMPH-NODE METASTASIS | ONCOLOGY | HIGH-DOSE LEUCOVORIN | Practice guidelines (Medicine) | Care and treatment | Cancer | Special
Journal Article
JAMA Surgery, ISSN 2168-6254, 10/2015, Volume 150, Issue 10, pp. 931 - 940
IMPORTANCE: Questions remain about the role and durability of bariatric surgery for type 2 diabetes mellitus (T2DM). OBJECTIVE: To compare the remission of...
INDIVIDUALS | SURGERY | INTENSIVE MEDICAL-MANAGEMENT | THERAPY | WEIGHT | Y GASTRIC BYPASS | Obesity - surgery | Gastric Bypass | Life Style | Obesity - complications | Humans | Middle Aged | Male | Treatment Outcome | Time Factors | Diabetes Mellitus, Type 2 - therapy | Adult | Female | Diabetes Mellitus, Type 2 - complications
INDIVIDUALS | SURGERY | INTENSIVE MEDICAL-MANAGEMENT | THERAPY | WEIGHT | Y GASTRIC BYPASS | Obesity - surgery | Gastric Bypass | Life Style | Obesity - complications | Humans | Middle Aged | Male | Treatment Outcome | Time Factors | Diabetes Mellitus, Type 2 - therapy | Adult | Female | Diabetes Mellitus, Type 2 - complications
Journal Article
Current critical care diagnosis & treatment, ISSN 1071-3964, 1994
Journal
International Journal of Clinical Oncology, ISSN 1341-9625, 4/2015, Volume 20, Issue 2, pp. 207 - 239
Colorectal cancer is a major cause of death in Japan, where it accounts for the largest number of deaths from malignant neoplasms among women and the third...
Chemotherapy | Medicine & Public Health | Surgery | Colorectal cancer | Oncology | Cancer Research | Guideline | Endoscopy | Radiotherapy | Surgical Oncology | INTENSIVE FOLLOW-UP | 1ST-LINE TREATMENT | FLUOROURACIL PLUS LEUCOVORIN | TOTAL MESORECTAL EXCISION | HEPATIC METASTASES | LYMPH-NODE METASTASIS | ONCOLOGY | HIGH-DOSE LEUCOVORIN | RANDOMIZED PHASE-III | PREOPERATIVE RADIOTHERAPY | SHORT-COURSE RADIOTHERAPY | Colonic Neoplasms - therapy | Lymph Node Excision | Humans | Japan | Neoplasm Recurrence, Local - therapy | Endoscopy, Gastrointestinal | Male | Palliative Care | Liver Neoplasms - therapy | Lymphatic Metastasis | Rectal Neoplasms - therapy | Intestinal Mucosa - surgery | Brain Neoplasms - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Brain Neoplasms - therapy | Female | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Neoplasm Staging | Radiotherapy, Adjuvant | Dissection | Practice guidelines (Medicine) | Care and treatment | Cancer | Special
Chemotherapy | Medicine & Public Health | Surgery | Colorectal cancer | Oncology | Cancer Research | Guideline | Endoscopy | Radiotherapy | Surgical Oncology | INTENSIVE FOLLOW-UP | 1ST-LINE TREATMENT | FLUOROURACIL PLUS LEUCOVORIN | TOTAL MESORECTAL EXCISION | HEPATIC METASTASES | LYMPH-NODE METASTASIS | ONCOLOGY | HIGH-DOSE LEUCOVORIN | RANDOMIZED PHASE-III | PREOPERATIVE RADIOTHERAPY | SHORT-COURSE RADIOTHERAPY | Colonic Neoplasms - therapy | Lymph Node Excision | Humans | Japan | Neoplasm Recurrence, Local - therapy | Endoscopy, Gastrointestinal | Male | Palliative Care | Liver Neoplasms - therapy | Lymphatic Metastasis | Rectal Neoplasms - therapy | Intestinal Mucosa - surgery | Brain Neoplasms - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Brain Neoplasms - therapy | Female | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Neoplasm Staging | Radiotherapy, Adjuvant | Dissection | Practice guidelines (Medicine) | Care and treatment | Cancer | Special
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2008, Volume 177, Issue 5, pp. 498 - 505
Rationale: The duration of antibiotic therapy in critically ill patients with sepsis can result in antibiotic overuse, increasing the risk of developing...
Sepsis | Intensive care | Controlled tria | Antibiotics | Procalcitonin | COMMUNITY-ACQUIRED PNEUMONIA | METAANALYSIS | intensive care | CONSENSUS CONFERENCE | procalcitonin | ORGAN FAILURE | THERAPY | controlled trial | INTENSIVE-CARE-UNIT | RESPIRATORY SYSTEM | DOUBLE-BLIND | SERUM PROCALCITONIN | antibiotics | CRITICALLY-ILL PATIENTS | sepsis | CRITICAL CARE MEDICINE | Calcitonin Gene-Related Peptide | Length of Stay | Recurrence | Calcitonin - blood | Protein Precursors - blood | Humans | Middle Aged | Clinical Protocols | Kaplan-Meier Estimate | Critical Illness | Male | Glycoproteins - blood | Shock, Septic - mortality | Sepsis - mortality | Sepsis - drug therapy | Algorithms | Shock, Septic - blood | Shock, Septic - drug therapy | Aged, 80 and over | Female | Aged | Sepsis - blood | Anti-Bacterial Agents - administration & dosage
Sepsis | Intensive care | Controlled tria | Antibiotics | Procalcitonin | COMMUNITY-ACQUIRED PNEUMONIA | METAANALYSIS | intensive care | CONSENSUS CONFERENCE | procalcitonin | ORGAN FAILURE | THERAPY | controlled trial | INTENSIVE-CARE-UNIT | RESPIRATORY SYSTEM | DOUBLE-BLIND | SERUM PROCALCITONIN | antibiotics | CRITICALLY-ILL PATIENTS | sepsis | CRITICAL CARE MEDICINE | Calcitonin Gene-Related Peptide | Length of Stay | Recurrence | Calcitonin - blood | Protein Precursors - blood | Humans | Middle Aged | Clinical Protocols | Kaplan-Meier Estimate | Critical Illness | Male | Glycoproteins - blood | Shock, Septic - mortality | Sepsis - mortality | Sepsis - drug therapy | Algorithms | Shock, Septic - blood | Shock, Septic - drug therapy | Aged, 80 and over | Female | Aged | Sepsis - blood | Anti-Bacterial Agents - administration & dosage
Journal Article
Cancer, ISSN 0008-543X, 01/2011, Volume 117, Issue 2, pp. 238 - 249
Asparaginases are a cornerstone of treatment protocols for acute lymphoblastic leukemia (ALL) and are used for remission induction and intensification...
ALL | acute lymphoblastic leukemia | asparaginase | Erwinia asparaginase | Erwinase | asparagine depletion | INTENSIVE ASPARAGINASE | ACUTE LYMPHOCYTIC-LEUKEMIA | ESCHERICHIA-COLI-ASPARAGINASE | CONSORTIUM PROTOCOLS | DOSE L-ASPARAGINASE | ERWINIA-ASPARAGINASE | IU/M PEG-ASPARAGINASE | ONCOLOGY | INTRAMUSCULAR THERAPY | PEDIATRIC-ONCOLOGY-GROUP | CANCER-STUDY-GROUP
ALL | acute lymphoblastic leukemia | asparaginase | Erwinia asparaginase | Erwinase | asparagine depletion | INTENSIVE ASPARAGINASE | ACUTE LYMPHOCYTIC-LEUKEMIA | ESCHERICHIA-COLI-ASPARAGINASE | CONSORTIUM PROTOCOLS | DOSE L-ASPARAGINASE | ERWINIA-ASPARAGINASE | IU/M PEG-ASPARAGINASE | ONCOLOGY | INTRAMUSCULAR THERAPY | PEDIATRIC-ONCOLOGY-GROUP | CANCER-STUDY-GROUP
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 06/2015, Volume 175, Issue 6, pp. 1026 - 1027
MEDICINE, GENERAL & INTERNAL | TREATMENT PREFERENCES | DECISION-MAKING | LIFE | Cardiopulmonary Resuscitation - statistics & numerical data | Advance Directives - statistics & numerical data | Humans | Female | Intensive Care Units - statistics & numerical data | Male | Advance Directive Adherence - statistics & numerical data | Life Support Care - statistics & numerical data
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 5/2019, Volume 45, Issue 5, pp. 637 - 646
Functional outcomes vary between centers after out-of-hospital cardiac arrest (OHCA) and are partially explained by pre-existing health status and arrest...
Pediatrics | Pain Medicine | Center variability | Out of hospital arrest | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Cardiac arrest | Intensive / Critical Care Medicine | Anesthesiology | NEUROLOGICAL RECOVERY | MANAGEMENT | MILD THERAPEUTIC HYPOTHERMIA | AMERICAN-HEART-ASSOCIATION | CARDIOPULMONARY-RESUSCITATION | CARE | PROGNOSTICATION | PREDICTION | COMATOSE SURVIVORS | ELEVATION MYOCARDIAL-INFARCTION | CRITICAL CARE MEDICINE | Heart | Demographics | Temperature | Demography | Catheterization | Adjustment | Variability | Diagnostic systems | Cardiopulmonary resuscitation--CPR | Patients | Resuscitation | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Anestesi och intensivvård | Anesthesiology and Intensive Care | Klinisk medicin
Pediatrics | Pain Medicine | Center variability | Out of hospital arrest | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Cardiac arrest | Intensive / Critical Care Medicine | Anesthesiology | NEUROLOGICAL RECOVERY | MANAGEMENT | MILD THERAPEUTIC HYPOTHERMIA | AMERICAN-HEART-ASSOCIATION | CARDIOPULMONARY-RESUSCITATION | CARE | PROGNOSTICATION | PREDICTION | COMATOSE SURVIVORS | ELEVATION MYOCARDIAL-INFARCTION | CRITICAL CARE MEDICINE | Heart | Demographics | Temperature | Demography | Catheterization | Adjustment | Variability | Diagnostic systems | Cardiopulmonary resuscitation--CPR | Patients | Resuscitation | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Anestesi och intensivvård | Anesthesiology and Intensive Care | Klinisk medicin
Journal Article